2013
DOI: 10.1016/j.apsb.2013.09.003
|View full text |Cite
|
Sign up to set email alerts
|

Characterization of a dextran–coated layered double hydroxide acetylsalicylic acid delivery system and its pharmacokinetics in rabbit

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
11
0

Year Published

2014
2014
2020
2020

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 21 publications
(12 citation statements)
references
References 10 publications
1
11
0
Order By: Relevance
“…192 Acetylsalicylic acid-dextran-coated LDH in vivo biocompatibility Dong et al designed drug-delivery systems based on dextrancoated LDHs for acetylsalicylic acid, and conducted a pharmacokinetic study with rabbits as the model animal. 160 They found the LDH-based delivery system increased the bioavailability and half-life and reduced the side effects of acetylsalicylic acid. 160 Table 2 summarizes the in vitro cytotoxic studies of inorganic nanolayers.…”
Section: Ketoprofen Ldh In Vivo Biocompatibilitymentioning
confidence: 99%
See 1 more Smart Citation
“…192 Acetylsalicylic acid-dextran-coated LDH in vivo biocompatibility Dong et al designed drug-delivery systems based on dextrancoated LDHs for acetylsalicylic acid, and conducted a pharmacokinetic study with rabbits as the model animal. 160 They found the LDH-based delivery system increased the bioavailability and half-life and reduced the side effects of acetylsalicylic acid. 160 Table 2 summarizes the in vitro cytotoxic studies of inorganic nanolayers.…”
Section: Ketoprofen Ldh In Vivo Biocompatibilitymentioning
confidence: 99%
“…160 They found the LDH-based delivery system increased the bioavailability and half-life and reduced the side effects of acetylsalicylic acid. 160 Table 2 summarizes the in vitro cytotoxic studies of inorganic nanolayers.…”
Section: Ketoprofen Ldh In Vivo Biocompatibilitymentioning
confidence: 99%
“…In the physiological condition, the positively charged drug-LDH is likely to tend to aggregate each other as well as to bind with nonspecific foreign substances in the bloodstream which are commonly negatively charged when clinically administrated into the human body. To increase the water solubility, bioavailability, circulation time, and accumulation in the targeted sites, those nanohybrids can be additionally coated with hydrophilic surfactants, lipid, enteric polymers, biopolymers, and biodegradable copolymers, e.g., tween [77], dextran [64,78], phospholipid [79], polyethylene glycol (PEG) [80], PEGylated phospholipid [65], Eudragit ® L100 [81], Eudragit ® S100 [82], poly (lactic-co-glycolic acid) (PLGA) [83,84], and heparin [66] (Fig. 6c).…”
Section: Bio-ldh Nanohybrids With Targeting Functionsmentioning
confidence: 99%
“…Recently, we develop acetyl salicylic acid (ASA)‐ZnAl‐LDH nanohybrid for skin care application . ASA is a salicylate derivative which possesses anti‐inflammatory effect, and for this reason, it is extensively used for pain relief in topical after shave skincare products . However, in presence of moisture it undergoes hydrolysis into salicylic and acetic acids, which reduces its pain relief effect and develops undesirable smell.…”
Section: Controlled Release Systems For Drugsmentioning
confidence: 99%